Wall Street brokerages predict that Addus Homecare Co. (NASDAQ:ADUS) will report sales of $172.85 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Addus Homecare’s earnings, with the lowest sales estimate coming in at $160.70 million and the highest estimate coming in at $181.70 million. Addus Homecare reported sales of $149.69 million in the same quarter last year, which indicates a positive year over year growth rate of 15.5%. The company is scheduled to report its next quarterly earnings results on Monday, August 3rd.
On average, analysts expect that Addus Homecare will report full-year sales of $745.62 million for the current fiscal year, with estimates ranging from $734.60 million to $750.60 million. For the next financial year, analysts expect that the business will report sales of $802.09 million, with estimates ranging from $798.02 million to $805.50 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Addus Homecare.
Addus Homecare (NASDAQ:ADUS) last released its earnings results on Monday, May 4th. The company reported $0.69 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.56 by $0.13. The firm had revenue of $190.20 million during the quarter, compared to analysts’ expectations of $181.08 million. Addus Homecare had a net margin of 3.35% and a return on equity of 8.00%.
Several research firms have commented on ADUS. Robert W. Baird lifted their target price on shares of Addus Homecare from $96.00 to $100.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 17th. They noted that the move was a valuation call. Royal Bank of Canada reissued a “buy” rating and set a $98.00 price objective on shares of Addus Homecare in a research note on Monday, April 20th. Sidoti boosted their price objective on shares of Addus Homecare from $96.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, June 1st. BidaskClub cut shares of Addus Homecare from a “hold” rating to a “sell” rating in a research note on Wednesday, June 10th. Finally, Zacks Investment Research cut shares of Addus Homecare from a “buy” rating to a “hold” rating in a research note on Thursday, June 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $99.63.
In related news, EVP Darby Anderson sold 6,000 shares of Addus Homecare stock in a transaction on Monday, June 1st. The shares were sold at an average price of $98.90, for a total transaction of $593,400.00. Following the transaction, the executive vice president now owns 32,064 shares in the company, valued at approximately $3,171,129.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Sean Gaffney sold 337 shares of Addus Homecare stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $81.62, for a total transaction of $27,505.94. Following the transaction, the executive vice president now owns 4,663 shares in the company, valued at approximately $380,594.06. The disclosure for this sale can be found here. Insiders own 20.10% of the company’s stock.
Hedge funds have recently modified their holdings of the business. Advisor Group Inc. lifted its holdings in Addus Homecare by 78.1% in the 4th quarter. Advisor Group Inc. now owns 472 shares of the company’s stock worth $46,000 after buying an additional 207 shares in the last quarter. Marshall Wace North America L.P. acquired a new position in Addus Homecare in the 1st quarter worth $34,000. Advisors Asset Management Inc. lifted its holdings in Addus Homecare by 232.0% in the 4th quarter. Advisors Asset Management Inc. now owns 571 shares of the company’s stock worth $56,000 after buying an additional 399 shares in the last quarter. Credit Agricole S A acquired a new position in Addus Homecare in the 1st quarter worth $40,000. Finally, Ladenburg Thalmann Financial Services Inc. lifted its holdings in Addus Homecare by 27.0% in the 4th quarter. Ladenburg Thalmann Financial Services Inc. now owns 724 shares of the company’s stock worth $70,000 after buying an additional 154 shares in the last quarter. Hedge funds and other institutional investors own 96.04% of the company’s stock.
ADUS stock traded up $1.20 during midday trading on Friday, hitting $92.51. The stock had a trading volume of 1,502 shares, compared to its average volume of 130,879. The company has a quick ratio of 5.07, a current ratio of 5.07 and a debt-to-equity ratio of 0.15. Addus Homecare has a 12-month low of $43.13 and a 12-month high of $104.56. The company’s 50-day moving average price is $92.32 and its 200 day moving average price is $87.44.
Addus Homecare Company Profile
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
See Also: How dollar cost averaging works
Get a free copy of the Zacks research report on Addus Homecare (ADUS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.